MedPath

Effect of portalaca olearaca on oxidative stress status in patients with type 2 diabetes

Phase 2
Conditions
Type 2 diabetes mellitus.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT201203241485N9
Lead Sponsor
Vice chancellor for research, Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
42
Inclusion Criteria

Non- Insulin dependent type 2 diabetic Patients; Non-smokers and lack of alcohol use; Not consuming supplements two weeks before the study and during the study; Non-pregnant and non-lactating women; Aged 35-65 years; No Change in dosage and type of medications at least two months prior to study; No history of hepatic, renal, lung, cardiovascular, kidney stone, thyroid diseases and gastro-intestinal bleeding; No history of myocardial infarction and stroke; Not affected by Severe non-proliferative or proliferative retinopathy; Not affected by malignant hypertension.
Exclusion criteria:
Change in diet or physical activity patterns during the study; injection of Insulin during study; Changes in dosage and type of medications throughout the study; Unwillingness to continue.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum Malondialdehyde level. Timepoint: At baseline and after each phase of intervention. Method of measurement: Commercial kits.;Serum oxidized LDL level. Timepoint: At baseline and after each phase of intervention. Method of measurement: Commercial kits.;Total antioxidant capacity level. Timepoint: At baseline and after each phase of intervention. Method of measurement: Commercial kits.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath